Home Medtronic EVP Gregory L. Smith Announces Retirement and Transition to Private Equity Firm

Medtronic EVP Gregory L. Smith Announces Retirement and Transition to Private Equity Firm

Nov 05, 2025 09:49 CST Updated 09:49
Medtronic

Medical Device Manufacturer

Image

Medtronic announced that the Executive Vice President of Corporate OperationsGregory L. Smith has notified the company of his decision to retire.


A portrait of Greg Smith, Medtronic's EVP of global operations and supply chain

Greg Smith, former EVP of enterprise operations. 


According to Medtronic,According to a filing with the U.S. Securities and Exchange Commission on November 3, 2025, Smith plans to retire on December 2, 2025. According to the document, he informed the company of his decision on November 1.


After retiring from Medtronic, Smith plans to join an unnamed private equity firm. From that day onward, he will be eligible for retirement benefits related to outstanding equity compensation. The retirement treatment of the equity includes the acceleration of unvested stock options and the continued vesting of restricted stock units (RSU) and Performance Stock Units (PSU).


Medtronic did not disclose more details about Smith's retirement, his expected destination, or any succession plans.


Smith joined Medtronic in 2021 as Executive Vice President of Global Operations and Supply Chain. Prior to joining Medtronic, he served as Executive Vice President of the U.S. supply chain at retail giant Walmart. There, he developed and implemented a strategy to reform Walmart's supply chain, striving to drive sales, reduce costs, while creating an attractive work environment.








▲ Source of the article: Medical Device Innovation Network
▲Please indicate the above source for reprint.

Disclaimer: This article is intended solely for the purpose of information transmission and reference only. It does not constitute any advice on investment or treatment; please exercise caution. If it involves issues related to the content, copyright, or other aspects of the work, to protect the rights and interests of both parties, please contact us and we will handle it immediately. If this article is reprinted by other platforms, the platform must take responsibility for the article itself. The Medical Device Innovation Network is not responsible for any secondary dissemination caused by reprints.

Image

Previous Recommendations

Countdown to Delisting for Medical Device Leader Amid Financial Fraud

Mindray Strikes Again!

Olympus, New Product

This Medical Device Company in Suzhou Secures Nearly 100 Million Yuan in Financing!

Image